Latest Investment News

Spheria Emerging Companies Limited has announced its highest-ever quarterly dividend of 3.6 cents per share, fully franked and payable in August 2025, reflecting strong long-term portfolio returns despite recent market volatility.

KKR Credit Income Fund has lifted the suspension of its Distribution Reinvestment Plan, allowing eligible unitholders in Australia and New Zealand to reinvest distributions into additional units starting from the July 2025 distribution.

Fat Prophets Global Contrarian Fund has announced a fully franked special dividend of 5 cents per share, reflecting strong investment performance. The dividend reinvestment plan offers shareholders a 2.5% discount on reinvested shares, signaling confidence in future growth.

Meteoric Resources has successfully raised $42.5 million through an oversubscribed placement, underpinning its push towards a Final Investment Decision for the Caldeira Rare Earth Project in 2026.

Aerometrex has completed a strategic review that delivers $2 million in cost savings and initiates data monetisation, positioning the company for accelerated growth in FY26.

DigitalX Limited has expanded its Bitcoin holdings by acquiring an additional 74.7 BTC, pushing its total treasury value beyond A$100 million and reinforcing its Bitcoin-first strategy.

Emmerson Resources’ latest Scoping Study confirms the White Devil Gold Project as a Major Mine, projecting robust financial returns and a seven-year mine life. With feasibility studies underway and a strategic JV structure, the project is poised for development in the Northern Territory.

West Wits Mining has released an updated Definitive Feasibility Study for its Qala Shallows project, revealing significant financial improvements and increased ore reserves. The study highlights a stronger gold price environment and refined mine plans that reduce capital requirements and accelerate payback.

Talius Group has reported a net profit of $0.37 million for Q2 2025, driven by a 6% increase in subscriptions and strategic partnerships that expand its market reach in aged care technology.

NeuroScientific Biopharmaceuticals has completed its acquisition of StemSmart technology, reporting promising clinical results in Crohn’s disease and GVHD, alongside a $3.5 million capital raise to fuel next-stage development.

Elsight Limited has raised A$60 million through a strongly supported placement, marking a milestone with consecutive record revenues and cash flow breakeven. The company is poised to capitalize on surging defence budgets and expanding drone markets with a robust pipeline of opportunities.

Elsight Limited reports a record 340% revenue surge to US$4.8 million in the first half of 2025, backed by a robust US$11.45 million contract backlog and a strategic A$60 million capital raise to fuel expansion.